Aggressive blood pressure control in general practice (ABC-GP) study: Can the new targets be reached?

Journal of Human Hypertension

Volumn 17, Issue 11, 2003, Pages 767-773

  Stergiou, G S ^a   Karotsis, A K ^b   Symeonidis, A ^b   Vassilopoulou, V A ^a  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b Greek Assoc of Gen Practitioners   (Greece)

Author keywords

Blood pressure control; Individualized treatment; Primary care; Stepwise treatment; Systolic blood pressure

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANTIHYPERTENSIVE AGENT; CHLORTALIDONE; DILTIAZEM; FELODIPINE; FOSINOPRIL; LACIDIPINE;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE CONTROL; DOSE CALCULATION; DRUG EFFECT; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; PERFORMANCE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SYSTOLIC BLOOD PRESSURE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; DRUG ADMINISTRATION SCHEDULE; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT-CENTERED CARE;

EID: 0344876496     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001610     Document Type: Article

References (25)

1. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 24: 2413-2446.
2. Marques-Vidal P, Tuomilehto J. Hypertension awareness, treatment and control in the community: Is the "rule of halves" still valid? J Hum Hypertens 1997; 11: 213-223.
3. Burt VL et al. Prevalence of hypertension in the US adult population. Results from the third National Health and Nutrition Examination Survey 1988-1991. Hypertension 1995; 25: 305-313.
4. Stergiou GS, Thomopoulou GC, Skeva II, Mountokalakis TD. Prevalence, awareness, treatment and control of hypertension in Greece: The Didima study. Am J Hypertens 1999; 12: 959-965.
5. Hansson L et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998; 351: 1755-1762.
6. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998; 317: 703-713.
7. 1999 World Health Organization - 1999 World Health Organization - International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-183.
8. Wester PO, Bjorck JE. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomized trial. Lancet 1999; 353: 611-616.
9. Hansson L et al. Randomized trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999; 354: 1751-1756.
10. The Heart Outcomes Prevention Evaluation Study (HOPE) Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145-153.
11. Brown MJ et al. Influence of diabetes and type of hypertension on response to antihypertensive treatment. Hypertension 2000; 35: 1038-1042.
12. Kjeldsen SE et al. Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: The LIFE study. Losartan Intervention for Endpoint. Am J Hypertens 2000; 13: 899-906.
13. Mann J, Julius S. The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design. Blood Press 1998; 7: 176-183.
14. Ramsay LE et al. Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society. J Hum Hypertens 1999; 13: 569-592.
15. Feldman RD et al. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension. CMAJ 1999; 161: S1-S17.
16. O'Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: The Omron HEM-705CP, Philips HP5332 and Nissei DS-175. Blood Press Monit 1996; 1: 55-61.
17. Beevers DG. Blood pressure that falls on rechecking. Br Med J 1982; 284: 71-72.
18. Pickering TG et al. How common is white coat hypertension. JAMA 1988; 259: 225-228.
19. MacMahon S et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-774.
20. Julius S. Therapeutic control of systolic blood pressure: What do trials teach us. Seventh International Forum for the Evaluation of Cardiovascular Care (IFECC-VI). Monte-Carlo 2002. Abstract book, 47 pp.
21. Berlowitz DR et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339: 1957-1963.
22. Fagard RH, Van Den Enden M, Leeman M, Warling X. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens 2002; 20: 1297-1302.
23. Oliveria SA et al. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002; 162: 413-420.
24. Izzo JL, Levy D, Black HR. Importance of systolic blood pressure in older Americans. Hypertension 2000; 35: 1021-1024.
25. Strategies for improving control of systolic blood pressure. Continuing Medical Education Web-Cast Series American Society of Hypertension. May 2002-May 2003. www.ash-us.org.